Phase I/II Trial of MUC1*-CAR-1XX T Cells

被引：0

作者：

Bamdad, Cynthia ^{[1
]}

Mortimer, Joanne ^{[2
]}

Yuan, Yuan ^{[2
]}

Specht, Jennifer ^{[3
]}

Stewart, Andrew ^{[1
]}

Smagghe, Benoit ^{[1
]}

Lin, Stephen ^{[2
]}

Carter, Mark ^{[1
]}

Synold, Tim ^{[2
]}

Parekh, Vishwas ^{[2
]}

Walkley, Danica ^{[1
]}

Budde, Lihua E. ^{[2
]}

Liu-Michael, Qing ^{[2
]}

Yi, Kevin ^{[1
]}

Nash, Jac-Leen ^{[1
]}

Nash, Michael ^{[1
]}

Marquez, Jacy ^{[1
]}

Kim, Teresa ^{[2
]}

Hamilton, Stan ^{[2
]}

Forman, Stephen J. ^{[2
]}

机构：

[1] Minerva Biotechnol, Waltham, MA USA

[2] City Hope Natl Med Ctr, Duarte, CA USA

[3] Fred Hutchinson Canc Ctr, Seattle, WA USA

来源：

MOLECULAR THERAPY | 2023年 / 31卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

804

引用

页码：397 / 397

页数：1

共 50 条

[21] Local Effects of Regulatory T Cells in MUC1 Transgenic Mice Potentiate Growth of MUC1 Expressing Tumor Cells In Vivo
Sugiura, Daisuke
Denda-Nagai, Kaori
Takashima, Mitsuyo
Murakami, Ryuichi
Nagai, Shigenori
Takeda, Kazuyoshi
Irimura, Tatsuro
PLOS ONE, 2012, 7 (09):
[22] Phase I clinical trial of MUC1-targeted CAR-T cells with PD-1-knockout in the treatment of advanced breast cancer
Lin, Yiguang
Yin, Haibin
Zhou, Chao
Zhou, Ling
Zeng, Yanyi
Yao, Herui
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[23] Distinguishing Truncated and Normal MUC1 Glycoform Targeting from Tn-MUC1-Specific CAR T Cells: Specificity Is the Key to Safety
Posey, Avery D., Jr.
Clausen, Henrik
June, Carl H.
IMMUNITY, 2016, 45 (05) : 947 - 948
[24] T cell suppression as a mechanism for tolerance to MUC1 antigen in MUC1 transgenic mice
Chen, DS
Koido, S
Li, YQ
Gendler, S
Gong, JL
BREAST CANCER RESEARCH AND TREATMENT, 2000, 60 (02) : 107 - 115
[25] T cell suppression as a mechanism for tolerance to MUC1 antigen in MUC1 transgenic mice
Dongshu Chen
Shigeo Koido
Yongqing Li
Sandra Gendler
Jianlin Gong
Breast Cancer Research and Treatment, 2000, 60 : 107 - 115
[26] Inhibiting MUC1 a/b chain interaction mediates cytotoxicity of cells expressing MUC1: The MUC1 dyad oncoprotein as a functional target
Karmely, M.
Rubinstein, D. B.
Pichinuk, E.
Ziv, R.
Benhar, I.
Feng, N.
Wreschner, D. H.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[27] Development of a chimeric antigen receptor (CAR) to re-target human T-cells to MUC1
Wilkie, S
Brenner, MK
Taylor-Papadimitriou, J
Burchell, J
Maher, J
IMMUNOLOGY, 2005, 116 : 39 - 40
[28] 1ST-IN-HUMAN CAR T TARGETS THE GROWTH FACTOR RECEPTOR FORM OF MUC1
Bamdad, C.
Smagghe, B. J.
Carter, M. G.
Grant, T.
Page, D.
Yi, K. Y.
Nash, J.
Reale, L. M.
Nash, M. J.
Stewart, A. K.
CYTOTHERAPY, 2022, 24 (05) : S108 - S108
[29] MUC1 mucin-mediated regulation of human T cells
Agrawal, B
Longenecker, BM
INTERNATIONAL IMMUNOLOGY, 2005, 17 (04) : 391 - 399
[30] MUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T Cells
Agrawal, Babita
Gupta, Nancy
Konowalchuk, Jeffrey D.
FRONTIERS IN IMMUNOLOGY, 2018, 9

← 1 2 3 4 5 →